SCHEMBL3223579

SCHEMBL3223579

NCCC[C@H](NC(=O)CI)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 3/20 0.53
GNPAT O15228 1/20 0.49
SLC6A5 Q9Y345 1/20 0.48
NOD1 Q9Y239 6/20 0.44
CPB2 Q96IY4 2/20 0.41
SLC15A2 Q16348 1/20 0.41
GSR P00390 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
RNPEP Q9H4A4 1/20 0.38
RIMKLA Q8IXN7 1/20 0.38
NAALAD2 Q9Y3Q0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3215126 0.94 FOLH1 (0.60) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL3843262 0.94 FOLH1 (0.60) FOLH1GNPATSLC6A5NOD1CPB2
Ethylene SCHEMBL6545172 0.91 FOLH1 (0.57) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL2114736 0.86 FOLH1 (0.54) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL27860271 0.86 FOLH1 (0.54) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL2114733 0.86 FOLH1 (0.54) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL30834826 0.85 FOLH1 (0.57) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL22776223 0.83 FOLH1 (0.51) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL4814393 0.83 FOLH1 (0.60) FOLH1GNPATSLC6A5NOD1CPB2
SCHEMBL20880031 0.83 FOLH1 (0.51) FOLH1GNPATSLC6A5NOD1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3696281-A1 ARGINASE AS BIOMARKER AND DRUG TARGET FOR PCOS Johann Wolfgang Goethe-Universität Frankfurt am Main (DE) 2020-08-19 EP claimed
WO-2018064112-A1 TREATMENT OF ACUTE KIDNEY INJURY THE PENN STATE RESEARCH FOUNDATION (US) 2018-04-05 WO claimed
EP-2083812-B1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS UNIV GRONINGEN (NL) 2017-04-05 EP claimed
US-20150164930-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS RIJKSUNIVERSITEIT GRONINGEN (NL) 2015-06-18 US claimed
US-20100056480-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS Rijks Univesiteit Groningen 2010-03-04 US claimed
EP-2083812-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS Rijksuniversiteit Groningen (NL) 2009-08-05 EP claimed
WO-2008061612-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS RIJKSUNIVERSITEIT GRONINGEN (NL) 2008-05-29 WO claimed
EP-4623299-A1 METHOD AND TREATMENT Immunesignatures Pty Ltd (AU) 2025-10-01 EP disclosed
WO-2024108268-A1 METHOD AND TREATMENT ImmuneSignatures Pty Ltd (AU) 2024-05-30 WO disclosed
EP-3696281-A1 ARGINASE AS BIOMARKER AND DRUG TARGET FOR PCOS Johann Wolfgang Goethe-Universität Frankfurt am Main (DE) 2020-08-19 EP disclosed
WO-2018064112-A1 TREATMENT OF ACUTE KIDNEY INJURY THE PENN STATE RESEARCH FOUNDATION (US) 2018-04-05 WO disclosed
EP-2083812-B1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS UNIV GRONINGEN (NL) 2017-04-05 EP disclosed
US-20150164930-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS RIJKSUNIVERSITEIT GRONINGEN (NL) 2015-06-18 US disclosed
US-20120315281-A1 TREATMENT OF RENAL INJURY THE PENN STATE RESEARCH FOUNDATION (US) 2012-12-13 US disclosed
WO-2012158518-A1 TREATMENT OF RENAL INJURY THE PENN STATE RESEARCH FOUNDATION (US) 2012-11-22 WO disclosed
US-20100056480-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS Rijks Univesiteit Groningen 2010-03-04 US disclosed
EP-2083812-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS Rijksuniversiteit Groningen (NL) 2009-08-05 EP disclosed
WO-2008061612-A1 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS RIJKSUNIVERSITEIT GRONINGEN (NL) 2008-05-29 WO disclosed